Small Study Tests Colchicine for Moderate to Severe COVID-19
For patients with moderate-to-severe COVID-19, colchicine reduces the length of supplemental oxygen therapy and hospitalization.
COVID19
ACR Releases COVID-19 Vaccine Clinical Guidance for Patients With Rheumatic and Musculoskeletal Diseases
The American College of Rheumatology developed clinical guidance for the use of COVID-19 vaccines in patients with rheumatic and musculoskeletal diseases.
FDA Approves Emergency Use of Bamlanivimab Plus Etesevimab for COVID-19
The FDA has issued an Emergency Use Authorization for Lilly’s SARS-CoV-2 neutralizing antibodies bamlanivimab plus etesevimab.
Blood Types O and Rh-Negative Protective Against COVID-19
Investigators determined whether ABO and Rh blood groups were associated with risk for SARS-CoV-2 infection and severe COVID-19 illness.
Rheuminating About COVID-19: A Rheumatologist’s Perspective
In this episode, we get an insight into the current COVID-19 landscape from a rheumatologist’s perspective.
Review: COVID-19 Vasculitis or Novel Vasculitis Mimic?
In this interview, Richard Becker, MD, gives us an insight into COVID-19 vasculitis and its manifestations.
Janssen Requests Emergency Use Authorization for Single-Shot COVID-19 Vaccine
The EUA submission is based on data from the randomized, double-blind, placebo-controlled ENSEMBLE trial.
Inequities Seen in Accessing Telemedicine During COVID-19 Pandemic
During the COVID-19 pandemic period, there have been inequities in accessing telemedicine.
J&J Single-Dose COVID-19 Vaccine 66% Effective at Preventing Moderate/Severe Disease
Single-dose vaccine candidate JNJ-78436725 against COVID-19 met primary and key secondary end points.
Evaluating Mucocutaneous Symptoms of Multisystem Inflammatory Syndrome in Pediatric Patients
The mucocutaneous features seen in hospitalized children with MIS-C and how these findings are associated with the onset of systemic symptoms are characterized.
-
Loading...
-
Loading...
Next post in Pediatric Rheumatology
